"Established in 1957, Hannibal Clinic has been serving the communities of northeast Missouri for over 60 years. The group includes over 50 providers in 25 specialties. This multi-specialty group includes outreach clinics in Bowling Green, Center, Clarence, Monroe City, Mexico and Palmyra. It is the largest rural health clinic in Missouri. In addition to a full-service urgent care facility, Hannibal Clinic offers services including lab, radiology, MRI, CT, PET, Sleep Lab, Primary and Specialty Care."

During the past decade, Hannibal Clinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hannibal Clinic" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Baxalta now part of Shire" with 1 trials sponsored, "CSL Behring" with 1 trials sponsored, "Grifols Therapeutics LLC" with 1 trials sponsored and "Inhibrx, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hannibal Clinic" #1 collaborator was "Biogen" with 1 trials as a collaborator and "Vanderbilt University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hannibal Clinic" are "Idiopathic Pulmonary Fibrosis" (2 trials), "AATD" (1 trials), "Alpha-1 Antitrypsin Deficiency" (1 trials), "Alpha1-antitrypsin Deficiency" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Hannibal Clinic" in a lesser frequency.

Most popular intervention types in "Hannibal Clinic" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Astegolimab" (1 trials), "CSL312" (1 trials), "GLASSIA" (1 trials) and "INBRX-101/rhAAT-Fc" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hannibal Clinic" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hannibal Clinic". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hannibal Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hannibal Clinic, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".